Considering the positive correlation between UBR5 expression and glycolysis or the β-catenin signaling pathway and the inhibition of UBR5 expression by ECH in HCC, ECH may regulate HCC glycolysis and β-catenin signaling pathway by targeting UBR5. This evidence concerns the gene UBR5 and hepatocellular carcinoma.